Atlas Trials

Evaluate the Effects of Renal Impairment on the Pharmacokinetics and Pharmacodynamics

Clinical trial NCT05323136 · TERMINATED

Trial details

NCT number
NCT05323136
Sponsor
Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
ACS - Acute Coronary Syndrome
Start date
2022-04-15
Primary completion
2022-06-29
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.